Atomwise leverages AI for structure-based small molecule drug discovery, removing the barriers of physical screening that have limited the success of traditional methods.
Unlearn.AI is creating a computer simulation of patients to create a digital twin so as to reduce by half the number of patients required for clinical trials.
USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.